Weekly Research Analysts’ Ratings Changes for Veradermics (MANE)

A number of firms have modified their ratings and price targets on shares of Veradermics (NYSE: MANE) recently:

• 7/15/2026 – Veradermics was given a new $170.00 price target by UBS Group AG.
• 7/15/2026 – Veradermics is now covered by B. Riley Financial, Inc.. They set a “buy” rating and a $170.00 price target on the stock.
• 7/12/2026 – Veradermics was downgraded by Wall Street Zen from “hold” to “sell”.
• 7/7/2026 – Veradermics had its price target raised by Jefferies Financial Group Inc. from $138.00 to $182.00. They now have a “buy” rating on the stock.
• 6/16/2026 – Veradermics is now covered by Lifesci Capital. They set an “outperform” rating and a $135.00 price target on the stock.
• 6/14/2026 – Veradermics was upgraded by Wall Street Zen from “sell” to “hold”.
• 6/6/2026 – Veradermics was downgraded by Wall Street Zen from “hold” to “sell”.
• 6/2/2026 – Veradermics is now covered by Needham & Company LLC. They set a “buy” rating and a $136.00 price target on the stock.
• 5/26/2026 – Veradermics is now covered by Weiss Ratings. They set a “sell (d+)” rating on the stock.
• 5/18/2026 – Veradermics had its price target raised by Citigroup Inc. from $120.00 to $135.00. They now have a “buy” rating on the stock.

MANE is a global manufacturer and supplier of flavors, fragrances and ingredients for the food, beverage, personal care, household and fine fragrance markets. Headquartered in France, the company develops and produces aromatic solutions that are used by consumer goods companies, food processors, perfumers and formulators seeking sensory impact, taste modulation and olfactory character for their products.

The company’s product portfolio includes savory and sweet flavor systems, beverage concentrates, natural extracts, essential oils, fragrance compounds, cosmetic ingredients and specialty functional solutions such as taste enhancers and odor masking agents.